Nogo-A regulates myogenesis via interacting with Filamin-C
Authors
SunYoung Park ; Ji-Hwan Park ; Un-Beom Kang ; Seong-Kyoon Choi ; Ahmed Elfadl ; H M Arif Ullah ; Myung-Jin Chung ; Ji-Yoon Son ; Hyun Ho Yun ; Jae-Min Park ; Jae-Hyuk Yim ; Seung-Jun Jung ; Sang-Hyup Kim ; Young-Chul Choi ; Dae-Seong Kim ; Jin-Hong Shin ; Jin-Sung Park ; Keun Hur ; Sang-Han Lee ; Eun-Joo Lee ; Daehee Hwang ; Kyu-Shik Jeong
Among the three isoforms encoded by Rtn4, Nogo-A has been intensely investigated as a central nervous system inhibitor. Although Nogo-A expression is increased in muscles of patients with amyotrophic lateral sclerosis, its role in muscle homeostasis and regeneration is not well elucidated. In this study, we discovered a significant increase in Nogo-A expression in various muscle-related pathological conditions. Nogo-/- mice displayed dystrophic muscle structure, dysregulated muscle regeneration following injury, and altered gene expression involving lipid storage and muscle cell differentiation. We hypothesized that increased Nogo-A levels might regulate muscle regeneration. Differentiating myoblasts exhibited Nogo-A upregulation and silencing Nogo-A abrogated myoblast differentiation. Nogo-A interacted with filamin-C, suggesting a role for Nogo-A in cytoskeletal arrangement during myogenesis. In conclusion, Nogo-A maintains muscle homeostasis and integrity, and pathologically altered Nogo-A expression mediates muscle regeneration, suggesting Nogo-A as a novel target for the treatment of myopathies in clinical settings.